Q2 EPS Estimate for Palisade Bio Raised by Analyst
Palisade Bio, Inc. (NASDAQ:PALI – Free Report) – Equities researchers at Brookline Capital Management boosted their Q2 2025 EPS estimates for shares of Palisade Bio in a research report issued to clients and investors on Tuesday, May 13th. Brookline Capital Management analyst K. Raja now anticipates that the company will earn ($0.48) per share for […]
Palisade Bio, Inc. (NASDAQ:PALI – Free Report) – Equities researchers at Brookline Capital Management boosted their Q2 2025 EPS estimates for shares of Palisade Bio in a research report issued to clients and investors on Tuesday, May 13th. Brookline Capital Management analyst K. Raja now anticipates that the company will earn ($0.48) per share for […]
-etf-logo-1200x675.png?v=20240612131721&w=240&h=240&zc=2){kind=logo}
